Compile Data Set for Download or QSAR
Report error Found 284 Enz. Inhib. hit(s) with all data for entry = 11803
TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649389(US20240034743, Compound 79)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649390(US20240034743, Compound 80)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649335(US20240034743, Compound 78 | US20240034743, Compou...)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649393(US20240034743, Compound 83)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649394(US20240034743, Compound 84)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649394(US20240034743, Compound 84)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649391(US20240034743, Compound 81)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649381(US20240034743, Compound 72)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649382(US20240034743, Compound 73)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649379(US20240034743, Compound 70)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649379(US20240034743, Compound 70)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649380(US20240034743, Compound 71)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649385(US20240034743, Compound 76)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649385(US20240034743, Compound 76)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649386(US20240034743, Compound 77A)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649383(US20240034743, Compound 74)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649383(US20240034743, Compound 74)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649384(US20240034743, Compound 75)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649405(US20240034743, Compound 95)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649406(US20240034743, Compound 96)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649403(US20240034743, Compound 93)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649403(US20240034743, Compound 93)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649404(US20240034743, Compound 94)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649353(US20240034743, Compound 100 | US20240034743, Compo...)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649407(US20240034743, Compound 97)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649408(US20240034743, Compound 98)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649397(US20240034743, Compound 87)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649398(US20240034743, Compound 88)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649398(US20240034743, Compound 88)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649395(US20240034743, Compound 85)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649395(US20240034743, Compound 85)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649401(US20240034743, Compound 91)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649401(US20240034743, Compound 91)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649402(US20240034743, Compound 92)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649399(US20240034743, Compound 89)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649399(US20240034743, Compound 89)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649400(US20240034743, Compound 90)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649400(US20240034743, Compound 90)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649421(US20240034743, Compound 111)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649422(US20240034743, Compound 112)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649419(US20240034743, Compound 109)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649420(US20240034743, Compound 110)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649423(US20240034743, Compound 113)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649424(US20240034743, Compound 114)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649424(US20240034743, Compound 114)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649413(US20240034743, Compound 103)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649414(US20240034743, Compound 104)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649411(US20240034743, Compound 101)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor [L858R,T790M,C797S](Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649412(US20240034743, Compound 102)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

TargetEpidermal growth factor receptor(Human)
Qilu Pharmaceutical

US Patent
LigandPNGBDBM649417(US20240034743, Compound 107)
Affinity DataIC50: 1nMAssay Description:TBDMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/4/2024
Entry Details
US Patent

Displayed 1 to 50 (of 284 total ) | Next | Last >>
Jump to: